Hypertension Treatment in Nigeria: Hypertension Diabetes Integration Study- Formative Aim 3

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 2800 participants.

Also called NCT07589387

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose health services research
Phase
Not applicable
Enrolled
  • 2,800 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07589387
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Nigeria (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07589387. Allocation not applicable; no masking; primary purpose health services research. Start 2026-02-14 (actual); primary completion 2029-04-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Hypertension Treatment in Nigeria: Hypertension Diabetes Integration Study- Formative Aim 3
Acronym
HTN2
Condition
Diabete Mellitus
Intervention (Other)
Implementation of program based on WHO HEARTS-D guidelines
Intervention (Drug)
Metformin
Intervention (Drug)
Glimepiride
Intervention (Device)
Point-of-care blood glucose monitor (glucometer) and compatible test strips
Intervention (Behavioral)
HEARTS-D training and quarterly supportive supervision for community health extension workers (CHEWs)
Lead sponsor
Washington University School of Medicine (class: other)
Collaborator
National Heart, Lung, and Blood Institute (NHLBI) (class: US National Institutes of Health)
Collaborator
University of Abuja Teaching Hospital (class: other)

Record details

Record id
cardio:ct-nct07589387
Content hash
72f9ab5609814d64b1cebe362eff3418b853c085f3b620c51fc0e1ec0ec444e5